Univariate analysis
| Classification . | PFS . | OS . | ||
|---|---|---|---|---|
| No. (%) of events (2-y survival) . | P (log-rank) . | No. (%) of events (2-y survival) . | P (log-rank) . | |
| All | 140 (30.7) | 105 (58.0) | ||
| Intention to treatment | < .001 | < .001 | ||
| Donor | 85 (39.3) | 56 (66.0) | ||
| No donor | 55 (14.2) | 49 (42.4) | ||
| Time from autoSCT to relapse | .019 | .010 | ||
| 12 mo or less | 106 (27.5) | 82 (50.6) | ||
| More than 12 mo | 34 (39.0) | 23 (77.5) | ||
| Histology* | .416 | .089 | ||
| Nodular sclerosis | 103 (32.4) | 72 (61.2) | ||
| Other | 21 (24.7) | 19 (43.7) | ||
| Sex | .650 | .379 | ||
| Male | 88 (32.6) | 63 (59.5) | ||
| Female | 52 (27.7) | 42 (55.4) | ||
| Classification . | PFS . | OS . | ||
|---|---|---|---|---|
| No. (%) of events (2-y survival) . | P (log-rank) . | No. (%) of events (2-y survival) . | P (log-rank) . | |
| All | 140 (30.7) | 105 (58.0) | ||
| Intention to treatment | < .001 | < .001 | ||
| Donor | 85 (39.3) | 56 (66.0) | ||
| No donor | 55 (14.2) | 49 (42.4) | ||
| Time from autoSCT to relapse | .019 | .010 | ||
| 12 mo or less | 106 (27.5) | 82 (50.6) | ||
| More than 12 mo | 34 (39.0) | 23 (77.5) | ||
| Histology* | .416 | .089 | ||
| Nodular sclerosis | 103 (32.4) | 72 (61.2) | ||
| Other | 21 (24.7) | 19 (43.7) | ||
| Sex | .650 | .379 | ||
| Male | 88 (32.6) | 63 (59.5) | ||
| Female | 52 (27.7) | 42 (55.4) | ||
autoSCT indicates autologous transplantation.
The sum does not add to the total because of missing data.